Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
DOMAIN PARTNERS VIII
- As of  06/25/19, 12:19:00 AM:   26 Insider Transactions.

Email this page to a friend.

Buy/Sell* 1 Yr Return** Filed Date Subject Symbol Pct Owned Details
B 2019-05-13 16:46:10.0 Alliqua BioMedical ALQA 28.29% view
B 2019-01-11 10:59:14.0 BioNano Genomics BNGO 9.5% view
S 2019-01-11 10:53:22.0 VERACYTE VCYT 5.6% view
B 2018-11-05 10:30:46.0 Dicerna Pharmaceuticals Inc DRNA 28.7% view
B 2018-01-08 09:58:37.0 VERACYTE VCYT 25.43% view
B 2017-12-20 16:37:20.0 Dicerna Pharmaceuticals Inc DRNA 28.7% view
B 2017-12-14 12:07:18.0 Ocera Therapeutics OCRX 28.7% view
B 2017-04-20 09:51:33.0 Dicerna Pharmaceuticals Inc DRNA 22.67% view
B 2017-01-09 12:58:11.0 Syndax Pharmaceuticals Inc SNDX 50.81% view
S 2016-01-19 16:13:19.0 Otonomy OTIC 3.4% view
B 2016-01-19 16:09:35.0 GLAUKOS Corp GKOS 6.4% view
S 2016-01-19 16:03:05.0 Atara Biotherapeutics ATRA 5.7% view
B 2016-01-19 15:58:46.0 aTYR PHARMA INC LIFE 7.6% view
S 2015-08-18 18:13:14.0 ACHILLION PHARMACEUTICALS INC ACHN 4.1% view
S 2015-05-22 16:46:12.0 ACHILLION PHARMACEUTICALS INC ACHN 4.7% view
B 2015-02-05 15:08:10.0 Otonomy OTIC 7.5% view
B 2015-02-05 14:57:54.0 Atara Biotherapeutics ATRA 10.6% view
S 2015-02-05 09:30:51.0 VERACYTE VCYT 12.3% view
B 2015-02-05 08:50:11.0 Dicerna Pharmaceuticals Inc DRNA 10.0% view
S 2014-09-11 17:02:19.0 ACHILLION PHARMACEUTICALS INC ACHN 7.3% view
B 2014-02-06 10:56:39.0 VERACYTE n/a 14.5% view
B -36.07% 2013-07-25 17:21:19.0 Ocera Therapeutics OCRX 16.7% view
S 2013-01-18 14:51:58.0 ACHILLION PHARMACEUTICALS INC ACHN 10.4% view
B 12.04% 2012-08-02 14:28:11.0 Durata Therapeutics DRTX 17.4% view
S 2012-06-15 12:01:02.0 ACHILLION PHARMACEUTICALS INC ACHN 13.0% view
B 130.77% 2010-08-30 16:54:40.0 ACHILLION PHARMACEUTICALS INC ACHN 17.6% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.
** Since most institutions are long investors, only returns for long transactions are shown here.